Abstract
Kijimicin represents an important type of ionophore compound. In veterinary medicine, it is becoming important as anticoccidiostatic agent and feed supplement. We examined Kijimicin for its HIV inhibitory activity. The compound exhibited concentration-dependent inhibition of HIV replication in primary infected cultures of human T-lymphoblastoid H9 cells. Substantial inhibition of viral replication was observed at concentrations of Kijimicin that showed little cytotoxicity. The ratio of IC50 values for the MTT to RT assays was 40. Anti HIV activity was also observed in cultures of monocytic lineage U937 cells chronically infected with HIV. Moreover, in attempting to define the inhibitory mechanism of Kijimicin, we investigated its effect on each step of HIV replication. The infectivity of progeny viral particles was reduced by Kijimicin treatment. This decrease may be due to incompletely glycosylated forms of gp120.
Similar content being viewed by others
References
Takahashi Y, Nakamura H, Ogata R, Matsuda N, Naganawa H, Taki-ta T, Iitaka Y, Sato K, Takeuchi T: Kijimicin, a polyether antibiotic. J Antibiotics 43: 441–443, 1990
Nakamura M, Ohno T, Kunimoto S, Naganawa H, Takeuchi T: Kijimicin: An inhibitor of human immunodeficiency virus in acutely and chronically infected cells. J Antibiotics 44: 569–571, 1991
Ito M, Baba M, Sato A, Panwels R, De Clercq E, Shigeta S: Inhibition effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV)in vitro. Antiviral Res 7: 361–367, 1987
Mitsuya H, Looney DJ, Kuno S, Ueno R, Wong-Staal F, Broder S: Dextran sulfate suppression of viruses in the HIV family: Inhibition binding to CD4+ cells. Science 240: 646–649, 1988
Popovic M, Sarngadharan MG, Read E, Gallo RC: Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224: 497–550, 1984
Chantal Petit AJ, Terpstra FG, Meidema F: Human immunodeficiency virus infection down-regulates HLA class II expression and induces differentiation in promonocytic U937 cells. J Clin Invest 79: 361–367, 1987
Hoffman AD, Banapour B, Levy JA: Characterization of the AIDS associated retroviruses reverse transcriptase and optical conditions for its detectionin vitro. Virology 147: 326–335, (1985)
Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63, 1983
Twentyman PR, Luscombe M: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemotherapy. Br J Cancer 56: 279–285, 1987
Hattori T, Shiozaki K, Eda Y, Tokiyoshi S, Matsushita A, Inaba H, Fujimaki M, Mguro T, Yamada K, Honda M: Characteristics of the principal neutralizing determinent of HIV-1 prevalent in Japan. AIDS Res Hum Retroviruses 7: 825–830, 1991
Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N: Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350–1354, 1985
Dalgleish AG, Beverley PCL, Clapham PR, Weiss RA, Axel R: The CD4 antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763–766, 1984
Maddon PJ, Dalgleish AG, McDougal J, Clapham PR, Weiss RA, Axel R: The T4 gene encodes the AIDS virus receptors and expressed in the immune system and the brain. Cell 47: 333–348, 1986
Gartner S, Markovits P, Markovits DM, Kaplan MH, Gallo RC, Popovic M: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233: 215–219, 1986
Gendelman HE, Orenstein JM, Baca LM, Weiser B, Burger H, Kalter DC, Meltzer MS: The macrophage in the persistence and pathogenesis of HIV infection. AIDS 3: 475–496, 1989
Ho DD, Rota TR, Hirsch MS: Infection of monocyte macrophages by human T lymphotropic virus type III. J Clin Invest 77: 1712–1715, 1986
Furman PA, Fyfe JA, St. Clair MH, Weinhold K, Rideout JL, Freeman GA, Nusinoff-Lehrman S, Bolognesi DP, Brider S, Mitsuya H, Barry DW: Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 83: 8333–8337, 1986
Dewar RI, Vasudevachari MB, Natarajan V, Salzman NP: Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: Effects of monencin on glycosylation and transport. J Virol 6: 2452–2456, 1989
Datema R, Olofsson S, Romero PA: Inhibitors of protein processing in viral systems. Pharmacol Ther 33: 221–286, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamauchi, T., Nakamura, M., Honma, H. et al. Mechanistic effects of kijimicin on inhibition of human immunodeficiency virus replication. Mol Cell Biochem 119, 35–41 (1993). https://doi.org/10.1007/BF00926851
Issue Date:
DOI: https://doi.org/10.1007/BF00926851